✦ LIBER ✦

6053 Phase II study of capecitabine, irinotecan (CAPIRI) plus bevacizumab in chemotherapy naive stage IV colorectal cancer, results in 120 patients

✍ Scribed by Fonseca, P.; Vieitez, J.M.; Berros, J.P.; Crespo, G.; de Sanmamed, M. Fernandez; Muriel, C.; Izquierdo, M.; Pardo, P.; Lacave, A.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine, irinot

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Efficacy and safety of bevacizumab-based

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Phase II study of combined chemotherapy

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

Multicenter phase II study of second-lin

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB

Chronomodulated administration of oxalip

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of docetaxel plus enoxapa

✍ Robert, Francisco; Busby, Elizabeth; Marques, Marisa B; Reynolds, Robert E; Care 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 209 KB